Definium Therapeutics, Inc. has grown revenue 212% a year over three years and 212% a year over five. Revenue growth, 3-year annual rate: +212% (Biotechnology median +21%). Revenue growth, 5-year rate: +212%, growth has slowed since the five-year average. Years of annual history on file: 7, FY2019 to FY2025, as filed.

DFTXDefinium Therapeutics, Inc.

HealthcareUSD

$43.79

$8.8852 weeks$47.08

Is it growing?

Is DFTX growing?

Definium Therapeutics, Inc. has grown revenue 212% a year over three years and 212% a year over five.

+212%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +212%
Revenue growth, 5-year rate · +212% over three · growth has slowed since the five-year average
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›